Gts Securities LLC Lantheus Holdings, Inc. Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$77.7 - $123.62 $582,750 - $927,150	7,500 Added 86.21%	16,200 $1.78 Million
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $5,887 - $8,305	100 Added 1.16%	8,700 $698,000
Q1 2024 May 15, 2024	SELL	$51.07 - $68.26 $2.18 Million - $2.91 Million	-42,700 Reduced 83.24%	8,600 $535,000
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $1.81 Million - $2.53 Million	32,500 Added 172.87%	51,300 $3.18 Million
Q3 2023 Nov 15, 2023	BUY	$60.27 - $90.75 $1.13 Million - $1.71 Million	18,800 New	18,800 $1.31 Million

538

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.